Skip to main content
U2BIO CO., LTD. logo

U2BIO CO., LTD. — Investor Relations & Filings

Ticker · 221800 ISIN · KR7221800006 KO Human health and social work activities
Open in API
Filings indexed 227 across all filing types
Latest filing 2020-03-09 AGM Information
Country KR South Korea
Listing KO 221800

About U2BIO CO., LTD.

https://www.u2bio.co.kr/eng/main.do

U2BIO CO., LTD. is a healthcare technology company specializing in the integration of biotechnology (BT) and information technology (IT). The company provides a range of in vitro diagnostic services, including clinical laboratory tests and molecular diagnostics. Concurrently, it develops and offers digital healthcare solutions and medical IT services tailored for medical institutions such as hospitals and clinics. U2BIO focuses on delivering personalized healthcare services based on scientific data to support medical professionals and improve patient health outcomes.

Recent filings

Filing Released Lang Actions
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for U2Bio. It contains the meeting agenda, date, location, and detailed management reference materials (경영참고사항) including business overviews, industry analysis, and board activity reports. This is a standard proxy statement/information document provided to shareholders to inform them of the upcoming meeting and the items to be voted upon. In the context of the provided categories, this fits best as a Proxy Solicitation & Information Statement.
2020-03-09 Korean
주주총회소집결의
AGM Information Classification · 96% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집 결의) for the company U2Bio. It outlines the date, location, and agenda items (approval of financial statements, election of directors, and remuneration limits). This type of document is a standard proxy solicitation or notice of meeting sent to shareholders to inform them of upcoming voting matters, which falls under the Proxy Solicitation & Information Statement category.
2020-03-04 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the closure of the shareholder register (stock transfer suspension) for the purpose of determining shareholders for an upcoming Annual General Meeting. It does not contain the full report or proxy materials, but rather serves as a formal notice of a corporate action. Given it is a regulatory announcement that does not fit into specific categories like dividend or share issuance, it falls under the general regulatory filing category.
2019-12-12 Korean
기업설명회(IR)개최결과
Investor Presentation Classification · 95% confidence The document is a formal notification regarding the results of an Investor Relations (IR) meeting held by U2Bio. It lists the date, location, attendees, and agenda of the meeting. Since it is a short regulatory announcement confirming that an IR event took place and where the materials can be found, rather than the presentation slides themselves, it falls under the category of a regulatory filing announcement.
2019-10-23 Korean
전환가액의조정(제7회차)
Capital/Financing Update Classification · 95% confidence The document is an official announcement regarding the adjustment of the conversion price for convertible bonds (CB) issued by the company (U2Bio). This type of filing, which details changes to the capital structure or terms of financial instruments like convertible bonds, falls under the category of capital and financing updates.
2019-10-18 Korean
기업설명회(IR)개최
Investor Presentation Classification · 98% confidence The document is a short announcement regarding an upcoming Investor Relations (IR) event (기업설명회). It provides details such as the date, location, target audience, and purpose of the meeting. It explicitly states that the actual IR materials will be distributed at the event and a follow-up disclosure will be made later. Since this is an announcement of an event rather than the presentation itself, and it fits the criteria for a regulatory announcement of a corporate event, it is classified as a Regulatory Filing (RNS).
2019-10-10 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.